Cellular defense systems, including a variety of antioxidant molecules and enzymes such as superoxide dismutase, glutathione peroxidase and catalase, ensure that reactive oxygen species (ROS) are maintained at relatively low levels in normal conditions. 1) Arsenic and its compounds are welldocumented environmental toxicants 2) that induce oxidative damage by increasing the production of ROS. Oxidative damage has been suggested to play a key role in arsenicinduced toxicity.
3-7)Catalase protects cells from ROS-induced damage by catalyzing the breakdown of hydrogen peroxide (H 2 O 2 ) into oxygen and water. Arsenic has been demonstrated to decrease catalase expression both in animal tissues and cultured cells. Catalase activity is significantly decreased in the liver of rats treated with arsenite. [8][9][10] Arsenite treatment in vitro decreases catalase activity in human fibroblasts. 4) In a human keratinocyte cell line, it was also shown to decrease levels of catalase mRNA and protein.
11)Phosphatidylinositol 3-kinases (PI3Ks) are key components for the activation of Akt signaling. In the PI3K/Akt pathway, formation of 3-phosphoinositides by PI3K enables the activation of Akt by phosphoinositide-dependent protein kinases 1 and 2, which phosphorylate Akt at threonine residue 308 (Thr308) and serine residue 473 (Ser473), respectively. PI3K/Akt is thought to play a pivotal role in regulating cell proliferation, survival, metabolism and cancer progression. The PI3K/Akt pathway is downstream of c-Met receptor tyrosine kinase, a receptor for hepatocyte growth factor. [12][13][14] In c-Met-deficient mouse hepatocytes, the level of catalase protein is constitutively high, 15) suggesting that a cMet-dependent pathway is involved in catalase expression. Rat liver epithelial cells transformed by chronic exposure to arsenite show upregulated c-Met expression. Previous studies have demonstrated arsenite-induced activation of PI3K and c-Met-and PI3K-dependent inhibition of catalase expression. The aim of this study was to examine the involvement of c-Met-and PI3K-dependent pathways in arsenite-induced inhibition of catalase expression. Catalase mRNA and protein expression have been analyzed in human hepatoma cells treated with sodium arsenite and an inhibitor of either c-Met or PI3K.
MATERIALS AND METHODS
ChemicalsAll chemicals used were of reagent grade or higher and were obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.), unless otherwise specified.Cell Treatment Human hepatoma cell line HepG2 was Seoul 156-756, Korea. Received July 13, 2011; accepted August 10, 2011; published